LONG-TERM SURGICAL OUTCOMES AFTER VITRECTOMY FOR SYMPTOMATIC LAMELLAR MACULAR HOLES
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sung J. | - |
dc.contributor.author | Jang, Sun Y. | - |
dc.contributor.author | Moon, Darachui | - |
dc.contributor.author | Choi, Kyung S. | - |
dc.contributor.author | Jung, Gi Y. | - |
dc.date.accessioned | 2021-08-12T02:44:44Z | - |
dc.date.available | 2021-08-12T02:44:44Z | - |
dc.date.issued | 2012-10 | - |
dc.identifier.issn | 0275-004X | - |
dc.identifier.issn | 1539-2864 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/14797 | - |
dc.description.abstract | Purpose: To determine long-term surgical findings and outcomes after vitrectomy for symptomatic lamellar macular holes. Methods: This is a retrospective, consecutive, interventional case series. Sixteen patients (31 eyes) with lamellar macular holes and central visual loss participated in the study. All patients underwent 3-port pars plana vitrectomy with membranectomy and/or internal limiting membrane peeling and gas tamponade under the care of one author. Best-corrected visual acuity and optical coherence tomography appearance were determined preoperatively and postoperatively. Results: Final visual acuity improved more than 2 lines postoperatively in 18 eyes (58.1%) and decreased in 2 eyes (6.5%) leading to a mean gain of 0.18 logarithm of the minimum angle of resolution visual acuity during the mean follow-up period of 39 +/- 24 months (12-85 months). Twenty-eight eyes (90.3%) improved or normalized in foveal appearance on postoperative optical coherence tomography images of the macula, 1 eye remained unchanged, and 1 eye (3.2%) had chronic cystoid macular edema, 1 eye was unchanged, and 1 eye showed recurrence of lamellar macular hole. Conclusion: In patients with central visual loss from lamellar macular holes, vitrectomy, membranectomy, and/or internal limiting membrane peeling and gas tamponade appear to have a beneficial effect for a mean of 3 years. RETINA 32:1743-1748, 2012 | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
dc.title | LONG-TERM SURGICAL OUTCOMES AFTER VITRECTOMY FOR SYMPTOMATIC LAMELLAR MACULAR HOLES | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1097/IAE.0b013e3182551c3c | - |
dc.identifier.scopusid | 2-s2.0-84866937299 | - |
dc.identifier.wosid | 000309217800006 | - |
dc.identifier.bibliographicCitation | Retina, v.32, no.9, pp 1743 - 1748 | - |
dc.citation.title | Retina | - |
dc.citation.volume | 32 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 1743 | - |
dc.citation.endPage | 1748 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Ophthalmology | - |
dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
dc.subject.keywordPlus | OPTICAL-COHERENCE-TOMOGRAPHY | - |
dc.subject.keywordPlus | ULTRAHIGH-RESOLUTION | - |
dc.subject.keywordPlus | FOVEA CENTRALIS | - |
dc.subject.keywordPlus | PSEUDOHOLES | - |
dc.subject.keywordPlus | INTERFACE | - |
dc.subject.keywordPlus | FEATURES | - |
dc.subject.keywordAuthor | internal limiting membrane peeling | - |
dc.subject.keywordAuthor | lamellar macular hole | - |
dc.subject.keywordAuthor | membranectomy | - |
dc.subject.keywordAuthor | surgical treatment | - |
dc.subject.keywordAuthor | vitrectomy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.